THU0104 Both MRI and HAQ-DI can predict relapses following all treatment withdrawal in MTX-NAÏVE patients with RA in remission after 12 months of abatacept therapy in the avert trial

Research output: Contribution to journalConference abstract in journalResearch

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume76
Issue numbersuppl 2
Pages (from-to)240
ISSN0003-4967
DOIs
Publication statusPublished - 2017

ID: 196765933